Skip to content

Thought Leadership

The team at Navidence believe that contributing to the collective industry conversation on Real World Evidence and Real World Data is beneficial for everyone. Here are some examples of our work:

Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices.

Here are Navidence, the concept of Computable Operational Definitions (CODefs) are intrinsically driven by demands from regulators. In this guidance the FDA refer to the use of Operational Definitions that include 3 key components:

1) Time frame over which assessment occurs

2) Specific codes/component(s) assessed (e.g., via code lists)

3) Algorithm for combining the components (leading to positive identification or lack identification).

These are the fundamentals of CODefs.


"Computable Phenotypes" - Understanding Their Importance in Regulatory Submissions of RWE.

Our CEO Aaron Kamauu, spoke at ISPOR 2024 alongside Marie Bradley from the FDA and Scott DuVall from US Department for Veterans Affairs, to showcase how the Power of CODefs can be used to illustrate fit-for-purpose use of real world data sources to regulators.


Presented at ISPOR Annual Meeting, Atlanta. 4th-8th May 2024.


Objective Fit-4-Purpose Assessment of Real-World Data for Evidence Generation in Type 2
Diabetes Mellitus: A Trial Tokenization Approach

The Navidence Team working alongside our colleagues from Datavant showed how the use of CODefs can derive significant value in the assessment of the value of RWD Tokenisation, as well and providing robust evidence of quality and fit-for-purpose to regulatory agencies.


Presented at ISPOR Annual Meeting, Atlanta. 4th-8th May 2024.


Development of a Comprehensive List of Immunosuppresive Therapies to Enable a Multi-Data Source Globel Real World Effectiveness Program of Immunocompromised Patients

The Navidence Team working alongside a team from AstraZeneca, University of Utah School of Medicine, Veterans Association-Informatics and Computing, UPMC-University of Pittsburgh, to define and develop a comprehensive list of immunosuppressive medications in order to underpin CODef library development for further RWE Research use cases.


Presented at the ISPOR Europe, 2023. 12-15 Novemeber 2023, Copenhagen Denmark.

ISPOR 2022 AZ Navidence Paper

Development of Computable Operational Definitions to Maximize Comparability & Consistency Across a Multi-Data Source Global Real-World Effectiveness Program

The Navidence Team working alongside a team from AstraZeneca to develop source-agnostic Computable Operational Definitions (CODef) to support a multinational, multi-data source real-world effectiveness program.


Presented at the 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) | August 23–27, 2023, Halifax, Nova Scotia, Canada

SCOPE logo

SCOPE 2023

Clear, Consistent, and Computable Operational Definitions: Defining the Purpose and Data Needs for Real-World Evidence Generation


Our CEO, Aaron Kamauu presented at the recent SCOPE Summit 2023 discussing the regulatory drivers from the FDA and the benefits of utilizing Computable Operational Definitions (CODEF) to enable RWE Design in the Age of Data.

Discuss The Power of CODefs with one of our experts.

Interested in hearing more about the Power of Computable Operational Definitions?
We'd love to hear from you!